$ARTW
ARTS WAY MANUFACTURING CO INC

2014 Form 10-K Financial Statement

#000143774915001434 Filed on January 29, 2015

View on sec.gov

Income Statement

Concept 2014 2013 Q4 2013
Revenue $36.17M $7.210M $34.23M
YoY Change 5.68% 4.04% -6.13%
Cost Of Revenue $27.45M $5.510M $25.86M
YoY Change 6.13% 11.31% -2.12%
Gross Profit $8.725M $1.700M $8.366M
YoY Change 4.28% -13.71% -16.59%
Gross Profit Margin 24.12% 23.58% 24.44%
Selling, General & Admin $6.578M $1.320M $6.035M
YoY Change 8.99% 29.41% 12.39%
% of Gross Profit 75.39% 77.65% 72.14%
Research & Development $191.0K $130.0K $174.0K
YoY Change 9.77% 44.44% -47.27%
% of Gross Profit 2.19% 7.65% 2.08%
Depreciation & Amortization $907.0K $140.0K $704.0K
YoY Change 28.84% -33.33% -17.18%
% of Gross Profit 10.4% 8.24% 8.41%
Operating Expenses $7.060M $1.450M $6.549M
YoY Change 7.79% 30.63% 14.7%
Operating Profit $1.665M $250.0K $1.817M
YoY Change -8.38% -70.93% -57.94%
Interest Expense $351.9K -$70.00K $296.6K
YoY Change 18.63% -12.5% -172.35%
% of Operating Profit 21.14% -28.0% 16.32%
Other Income/Expense, Net -$362.3K $0.00 $388.7K
YoY Change -193.22% -100.0% 455.29%
Pretax Income $1.303M $190.0K $2.206M
YoY Change -40.95% -76.25% -44.72%
Income Tax $367.3K -$10.00K $654.5K
% Of Pretax Income 28.2% -5.26% 29.67%
Net Earnings $935.2K $190.0K $1.551M
YoY Change -39.72% -66.07% -41.9%
Net Earnings / Revenue 2.59% 2.64% 4.53%
Basic Earnings Per Share $0.23 $0.38
Diluted Earnings Per Share $0.23 $39.67K $0.38
COMMON SHARES
Basic Shares Outstanding 4.048M 4.040M
Diluted Shares Outstanding 4.053M 4.050M

Balance Sheet

Concept 2014 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $510.0K $210.0K $210.0K
YoY Change 142.86% -86.45% -86.45%
Cash & Equivalents $208.0K
Short-Term Investments $0.00
Other Short-Term Assets $1.390M $242.1K $1.470M
YoY Change -5.44% -82.33% 7.3%
Inventory $15.11M $14.92M $14.96M
Prepaid Expenses
Receivables $2.960M $3.000M $3.000M
Other Receivables $100.0K $110.0K $110.0K
Total Short-Term Assets $20.07M $19.75M $19.75M
YoY Change 1.62% -1.88% -1.89%
LONG-TERM ASSETS
Property, Plant & Equipment $11.74M $11.90M $12.02M
YoY Change -2.33% 20.2% 21.41%
Goodwill $993.7K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $50.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $12.78M $13.02M $13.02M
YoY Change -1.84% 17.26% 17.3%
TOTAL ASSETS
Total Short-Term Assets $20.07M $19.75M $19.75M
Total Long-Term Assets $12.78M $13.02M $13.02M
Total Assets $32.85M $32.77M $32.77M
YoY Change 0.24% 4.92% 4.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $870.0K $806.2K $810.0K
YoY Change 7.41% 24.03% 24.62%
Accrued Expenses $1.580M $1.718M $1.720M
YoY Change -8.14% -12.32% -12.24%
Deferred Revenue
YoY Change
Short-Term Debt $2.570M $3.350M $3.350M
YoY Change -23.28%
Long-Term Debt Due $1.280M $1.229M $1.230M
YoY Change 4.07% 5.04% 5.13%
Total Short-Term Liabilities $6.500M $7.269M $7.270M
YoY Change -10.59% 21.96% 21.98%
LONG-TERM LIABILITIES
Long-Term Debt $5.950M $6.252M $6.250M
YoY Change -4.8% -14.36% -14.38%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.950M $6.252M $6.250M
YoY Change -4.8% -14.36% -14.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.500M $7.269M $7.270M
Total Long-Term Liabilities $5.950M $6.252M $6.250M
Total Liabilities $13.59M $14.47M $14.47M
YoY Change -6.08% 2.21% 2.19%
SHAREHOLDERS EQUITY
Retained Earnings $15.64M
YoY Change
Common Stock $40.47K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.25M $18.29M $18.29M
YoY Change
Total Liabilities & Shareholders Equity $32.85M $32.77M $32.77M
YoY Change 0.24% 4.92% 4.93%

Cashflow Statement

Concept 2014 2013 Q4 2013
OPERATING ACTIVITIES
Net Income $935.2K $190.0K $1.551M
YoY Change -39.72% -66.07% -41.9%
Depreciation, Depletion And Amortization $907.0K $140.0K $704.0K
YoY Change 28.84% -33.33% -17.18%
Cash From Operating Activities $1.942M -$700.0K -$2.344K
YoY Change -82941.51% -125.09% -100.05%
INVESTING ACTIVITIES
Capital Expenditures $633.1K -$160.0K $842.1K
YoY Change -24.82% -40.74% -205.27%
Acquisitions
YoY Change
Other Investing Activities $20.00K -$3.020M -$2.500M
YoY Change -100.8% -16.67%
Cash From Investing Activities -$617.2K -$3.180M -$3.343M
YoY Change -81.54% 1123.08% -12.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.248M $1.214M
YoY Change 2.81%
Cash From Financing Activities -1.021M 2.660M 2.007M
YoY Change -150.88% -301.52% 772.4%
NET CHANGE
Cash From Operating Activities 1.942M -700.0K -2.344K
Cash From Investing Activities -617.2K -3.180M -3.343M
Cash From Financing Activities -1.021M 2.660M 2.007M
Net Change In Cash 303.8K -1.220M -1.339M
YoY Change -122.69% -200.83% -193.61%
FREE CASH FLOW
Cash From Operating Activities $1.942M -$700.0K -$2.344K
Capital Expenditures $633.1K -$160.0K $842.1K
Free Cash Flow $1.309M -$540.0K -$844.5K
YoY Change -254.98% -117.65% -114.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2014 artw Defined Contribution Plan Minimum Threshold Percentage Of Employee Contributions
DefinedContributionPlanMinimumThresholdPercentageOfEmployeeContributions
0.04
CY2014 artw Engineering Expense
EngineeringExpense
482057
CY2013 artw Engineering Expense
EngineeringExpense
514086
CY2014Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Maximum Inventory Amount
LineOfCreditFacilityBorrowingCapacityBorrowingBaseMaximumInventoryAmount
6000000
CY2014Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Minimum Percentage Of Aggregate Receivables
LineOfCreditFacilityBorrowingCapacityBorrowingBaseMinimumPercentageOfAggregateReceivables
0.2
CY2014Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Percentage Of Accounts Receivable
LineOfCreditFacilityBorrowingCapacityBorrowingBasePercentageOfAccountsReceivable
0.75
CY2014Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Percentage Of Inventory
LineOfCreditFacilityBorrowingCapacityBorrowingBasePercentageOfInventory
0.5
CY2014 artw Overdue Trade Receivables Interest Rate Percent Of Account Balances Per Month
OverdueTradeReceivablesInterestRatePercentOfAccountBalancesPerMonth
0.015
CY2013 artw Proceeds From Return Of Asset Held For Lease
ProceedsFromReturnOfAssetHeldForLease
146902
CY2014 artw Standard Product Warranty Term
StandardProductWarrantyTerm
P1Y
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4048552
CY2014Q2 dei Entity Public Float
EntityPublicFloat
12759986
CY2014 dei Entity Registrant Name
EntityRegistrantName
ARTS WAY MANUFACTURING CO INC
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000007623
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-11-30
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
874653
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
806207
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2961834
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2999903
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1584328
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1718475
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14838415
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14147653
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2638651
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2616407
CY2014 us-gaap Advertising Expense
AdvertisingExpense
511000
CY2013 us-gaap Advertising Expense
AdvertisingExpense
479000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14504
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29812
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
35474
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27958
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
35175
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35175
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35474
CY2014 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4839
CY2014Q4 us-gaap Assets
Assets
32846342
CY2013Q4 us-gaap Assets
Assets
32767621
CY2014Q4 us-gaap Assets Current
AssetsCurrent
20065961
CY2013Q4 us-gaap Assets Current
AssetsCurrent
19751372
CY2014Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
96382
CY2013Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
17721
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
511716
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207950
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1546609
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
303766
CY2013 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1338659
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4048552
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4046552
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4048552
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4046552
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
40486
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
40466
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Cash&nbsp;</div><div style="display: inline; font-weight: bold;">Concentration&nbsp;</div><div style=" MARGIN-BOTTOM: 0px; MARGIN-LEFT: 54pt; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company maintains several different accounts at four different banks, and balances in these accounts are periodically in excess of federally insured limits. However, management believes the risk of loss to be low.</div></div></div></div></div></div></div></div></div>
CY2014Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
8048
CY2013Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
0
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27445242
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
25860107
CY2014Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
17543
CY2013Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
42238
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
307452
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
765606
CY2014Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
95411
CY2013Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
147505
CY2014 us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
0.035
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
59806
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-111138
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
22000
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
24000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1259943
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1228097
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
147000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
168000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1091000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1036000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1141580
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.01
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
952645
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1142000
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
953000
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
145941
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54544
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
38145
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.01
CY2014 us-gaap Depreciation
Depreciation
906702
CY2013 us-gaap Depreciation
Depreciation
704457
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
907000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
704000
CY2014Q4 us-gaap Disposal Group Including Discontinued Operation Long Lived Assets
DisposalGroupIncludingDiscontinuedOperationLongLivedAssets
58500
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Long Lived Assets
DisposalGroupIncludingDiscontinuedOperationLongLivedAssets
122318
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.297
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.038
CY2013 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.033
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.02
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
673934
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
836200
CY2014 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2013 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3881
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7260
CY2013 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
17210
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6268
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
601678
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4205375
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3879580
CY2014Q4 us-gaap Goodwill
Goodwill
993729
CY2013Q4 us-gaap Goodwill
Goodwill
993729
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014 us-gaap Gross Profit
GrossProfit
8724569
CY2013 us-gaap Gross Profit
GrossProfit
8366446
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1302505
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2205844
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1303000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2206000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
367258
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
654468
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
299988
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
1644520
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
100417
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
108513
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
68447
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
151885
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33529
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
229412
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-821301
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-134147
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-279721
CY2014 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-52094
CY2013 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-84795
CY2014 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-157089
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1048125
CY2014 us-gaap Interest Expense
InterestExpense
351899
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-69559
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-67652
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
103356
CY2013 us-gaap Interest Expense
InterestExpense
296640
CY2014 us-gaap Interest Paid
InterestPaid
356470
CY2013 us-gaap Interest Paid
InterestPaid
296640
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8504062
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7305301
CY2014Q4 us-gaap Inventory Gross
InventoryGross
19008227
CY2013Q4 us-gaap Inventory Gross
InventoryGross
18138331
CY2014Q4 us-gaap Inventory Net
InventoryNet
15089280
CY2013Q4 us-gaap Inventory Net
InventoryNet
14922525
CY2013 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
111138
CY2014 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-8096
CY2013 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
108513
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
166755
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-769641
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10037055
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10322014
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3918947
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3215806
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
467110
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
511016
CY2014Q4 us-gaap Liabilities
Liabilities
13594686
CY2013Q4 us-gaap Liabilities
Liabilities
14473476
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32846342
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32767621
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6503777
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7268872
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
2569109
CY2014Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.035
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
8000000
CY2014Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2569106
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
87026
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1283897
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1959763
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2433936
CY2013Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3350000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
7233226
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
7480923
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1283897
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1228964
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1322663
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5949329
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6251959
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1020831
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2006524
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-617208
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3342839
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1941805
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2344
CY2014 us-gaap Net Income Loss
NetIncomeLoss
935247
CY2013 us-gaap Net Income Loss
NetIncomeLoss
1551376
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-362333
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
388704
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2014 us-gaap Operating Expenses
OperatingExpenses
7059731
CY2013 us-gaap Operating Expenses
OperatingExpenses
6549306
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
1664838
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
1817140
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
676128
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
661556
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
125229
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
242146
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47360
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10434
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
685344
CY2013 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
404655
CY2014 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
633000
CY2013 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
842000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633078
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
842124
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1000000
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
228339
CY2014 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-780894
CY2013 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3350000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
15870
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
835534
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7760
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
46390
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
234266
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
220719
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26519207
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26047855
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11680792
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11900202
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4540
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7516
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1247697
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1213550
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
191000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
174000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16572519
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15637272
CY2014 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
59000
CY2014 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
628000
CY2013 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
788000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
36169811
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
34226553
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2155640
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
14504
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
29812
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.01063
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2372299
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
19000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.17
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2100
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.18
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3228
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5371
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
155000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
143000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.81
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4020
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13970
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.04
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
19000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
14000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.17
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.64
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15400
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
143000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
160000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
163000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.72
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.16
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.88
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.15
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.10
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.40
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2014 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
421787
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15400
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
48400
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y98D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y259D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y51D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y259D
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
220719
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
578864
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
234266
CY2013 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
605281
CY2014 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
435334
CY2013 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
247136
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
19251656
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
18294145
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Use of Estimates</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 54pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management of the Company has made a number of estimates and assumptions related to the reported amount of assets and liabilities, reported amount of revenues and expenses, and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with generally accepted accounting principles. Actual results could differ from those estimates. </div></div></div></div></div></div></div>
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4907
CY2013 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10261
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4052703
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4049791
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4047796
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4039530

Files In Submission

Name View Source Status
0001437749-15-001434-index-headers.html Edgar Link pending
0001437749-15-001434-index.html Edgar Link pending
0001437749-15-001434.txt Edgar Link pending
0001437749-15-001434-xbrl.zip Edgar Link pending
artw-20141130.xml Edgar Link completed
artw-20141130.xsd Edgar Link pending
artw-20141130_cal.xml Edgar Link unprocessable
artw-20141130_def.xml Edgar Link unprocessable
artw-20141130_lab.xml Edgar Link unprocessable
artw-20141130_pre.xml Edgar Link unprocessable
artw20141130_10k.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending